Vicarious Surgical (RBOT) Total Non-Current Liabilities (2020 - 2025)
Vicarious Surgical (RBOT) posted quarterly Total Non-Current Liabilities of $14.7 million for Q3 2025, down 31.56% year-over-year from $21.5 million in Q3 2024, and down 13.43% quarter-over-quarter from $17.0 million in Q2 2025.
Vicarious Surgical (RBOT) Total Non-Current Liabilities (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Total Non-Current Liabilities for 6 consecutive years, with $14.7 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Total Non-Current Liabilities fell 31.56% year-over-year to $14.7 million; the TTM figure through Sep 2025 stood at $14.7 million (down 31.56% YoY), while the FY2024 annual figure was $20.2 million, down 3.94% from the prior year.
- Total Non-Current Liabilities eased to $14.7 million in Q3 2025 per RBOT's latest filing, from $17.0 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $27.0 million in Q3 2022 and bottomed at $5.4 million in Q3 2021.
- Historically, Total Non-Current Liabilities has averaged $18.7 million across 5 years, with a median of $20.4 million in 2024.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 396.12% — and 2025, when it sank 31.56%.
- Vicarious Surgical's Total Non-Current Liabilities stood at $8.6 million in 2021, then surged by 171.1% to $23.2 million in 2022, then declined by 9.3% to $21.1 million in 2023, then dropped by 3.94% to $20.2 million in 2024, then declined by 27.32% to $14.7 million in 2025.
- Business Quant data shows RBOT's Total Non-Current Liabilities at $14.7 million in Q3 2025, $17.0 million in Q2 2025, and $20.1 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Vicarious Surgical | 196,495.36 | -14.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 14.71 Mn |
| Jun 30, 2025 | 16.99 Mn |
| Mar 31, 2025 | 20.10 Mn |
| Dec 31, 2024 | 20.23 Mn |
| Sep 30, 2024 | 21.49 Mn |
| Jun 30, 2024 | 20.38 Mn |
| Mar 31, 2024 | 18.58 Mn |
| Dec 31, 2023 | 21.07 Mn |
| Sep 30, 2023 | 21.86 Mn |
| Jun 30, 2023 | 21.82 Mn |
| Mar 31, 2023 | 21.26 Mn |
| Dec 31, 2022 | 23.23 Mn |
| Sep 30, 2022 | 26.99 Mn |
| Jun 30, 2022 | 22.58 Mn |
| Mar 31, 2022 | 22.45 Mn |
| Dec 31, 2021 | 8.57 Mn |
| Sep 30, 2021 | 5.44 Mn |
| Jun 30, 2021 | 14.24 Mn |
| Mar 31, 2021 | 13.59 Mn |
| Dec 31, 2020 | -28.48 Mn |